XTX Topco Ltd trimmed its holdings in Nutrien Ltd. (NYSE:NTR - Free Report) by 79.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 4,422 shares of the company's stock after selling 17,301 shares during the period. XTX Topco Ltd's holdings in Nutrien were worth $220,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in NTR. Barclays PLC raised its holdings in Nutrien by 192.7% during the fourth quarter. Barclays PLC now owns 411,056 shares of the company's stock worth $18,395,000 after acquiring an additional 854,543 shares in the last quarter. Deutsche Bank AG raised its holdings in Nutrien by 11.3% during the fourth quarter. Deutsche Bank AG now owns 7,105,057 shares of the company's stock worth $317,951,000 after acquiring an additional 721,935 shares in the last quarter. Allianz Asset Management GmbH raised its holdings in Nutrien by 789.0% during the first quarter. Allianz Asset Management GmbH now owns 659,150 shares of the company's stock worth $32,709,000 after acquiring an additional 585,002 shares in the last quarter. TD Asset Management Inc raised its holdings in Nutrien by 10.0% during the first quarter. TD Asset Management Inc now owns 6,179,358 shares of the company's stock worth $306,645,000 after acquiring an additional 563,677 shares in the last quarter. Finally, Goehring & Rozencwajg Associates LLC raised its holdings in Nutrien by 235.2% during the first quarter. Goehring & Rozencwajg Associates LLC now owns 671,829 shares of the company's stock worth $35,237,000 after acquiring an additional 471,390 shares in the last quarter. 63.10% of the stock is owned by institutional investors and hedge funds.
Nutrien Price Performance
Shares of NTR traded up $0.03 during trading hours on Thursday, reaching $56.91. The stock had a trading volume of 1,715,113 shares, compared to its average volume of 2,046,443. Nutrien Ltd. has a 12 month low of $43.69 and a 12 month high of $65.08. The stock has a market capitalization of $27.71 billion, a PE ratio of 17.29, a PEG ratio of 1.04 and a beta of 0.81. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.85 and a current ratio of 1.33. The company's 50-day moving average is $59.69 and its two-hundred day moving average is $55.43.
Nutrien (NYSE:NTR - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported $2.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.41 by $0.24. The business had revenue of $10.30 billion during the quarter, compared to analyst estimates of $10.40 billion. Nutrien had a return on equity of 6.51% and a net margin of 5.25%. Nutrien's revenue for the quarter was up 2.8% compared to the same quarter last year. During the same period last year, the company earned $2.34 EPS. Research analysts expect that Nutrien Ltd. will post 3.72 EPS for the current year.
Nutrien Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 17th. Shareholders of record on Monday, September 29th will be issued a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 3.8%. The ex-dividend date is Monday, September 29th. Nutrien's dividend payout ratio (DPR) is presently 78.14%.
Wall Street Analyst Weigh In
Several analysts recently issued reports on NTR shares. Wells Fargo & Company upped their target price on Nutrien from $59.00 to $62.00 and gave the stock an "equal weight" rating in a report on Thursday, July 17th. Jefferies Financial Group reaffirmed a "hold" rating and issued a $66.00 target price (up previously from $63.00) on shares of Nutrien in a research report on Friday, July 11th. Scotiabank reaffirmed a "sector perform" rating and issued a $60.00 target price (down previously from $62.00) on shares of Nutrien in a research report on Monday. Wall Street Zen raised Nutrien from a "hold" rating to a "strong-buy" rating in a research report on Saturday, August 9th. Finally, UBS Group reduced their price target on Nutrien from $64.00 to $63.00 and set a "neutral" rating on the stock in a research report on Thursday, August 7th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating, six have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $62.65.
Get Our Latest Analysis on NTR
Nutrien Company Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Featured Articles

Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.